Predictive value of pro- and anti-inflammatory cytokines in assessing severity and outcome of acute pancreatitis;Prognostički značaj pro- i anti-inflamatornih citokina u proceni težine i ishoda akutnog pankreatitisa

Jugoslovenska Medicinska Biohemija

Volumn 24, Issue 4, 2005, Pages 253-257

  Mirković, Darko ^a,d,e   Šurbatović, Maja ^b,f   Filipović, Nikola ^b,f   Radaković, Sonja ^c,g  

^a Klinika za Op tu i Vaskularnu Hirurgiju VMA

^b Klinika za Anesteziologiju i Intenzivnu Terapiju VMA

^c Zavod za Preventivnu Medicinu VMA ^*

^d Klinika za Op tu i Vaskularnu Hirurgiju

^e Clinic of General and Vascular Surgery MMA

^f Clinic of Anesthesiology and Intensive Therapy MMA

^g Institute of Preventive Medicine   (India)

Author keywords

Acute pancreatitis; Cytokines; Outcome; Severity

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; PREDICTION; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME;

EID: 29144439811     PISSN: 03543447     EISSN: None     Source Type: Journal    
DOI: 10.2298/JMB0504253M     Document Type: Article

References (15)

1. Nathens AB, Curtis JR, Beale RJ, Cook DJ, Moreno RP, Romand JA, et al. Management of the critically ill patient with severe acute pancreatitis. Crit Care Med 2004; 32: 2524-36.
2. McKay CJ, Buter A. Natural history of organ failure in acute pancreatitis. Pancreatology 2003; 3: 111-4.
3. Van Westerloo DJ, Schultz MJ, Bruno MJ, De Vos AF, Florquin S, Van der Poll T. Acute pancreatitis in mice impairs bacterial clearence from the lungs, whereas concurrent pneumonia prolongs the course of pancreatitis. Crit Care Med 2004; 32: 1997-2001.
4. Pooran N, Indaram A, Singh P, Bank S. Cytokines (IL-6, 1L-8. TNF): early and reliable predictors of severe acute pancreatitis. J Clin Gastroenterol 2003; 37 (3): 263-6.
5. Bone RC, Grodzin CJ, Balk RA. Sepsis: A New Hypothesis for Pathogenesis of the Disease Process. Chest 1997; 112(1): 235-43.
6. Tjardes T, Neugebauer E. Sepsis research in the next millennium: concentrate on the software rather than the hardware. Shock 2002; 17 (1): 1-8.
7. Cook JW, Karakozis S, Kim D. Interleukin-10 Attenuates Proinflammatory Cytokine Production and Improves Survival in Lethal Pancreatitis. Am Surg 2001; 67(3): 237-42.
8. Simović MO, Bonham MJD, Abu-Zidan FM, Windsor JA. Antiinflammatory cytokine response and clinical outcome in acute pancreatitis. Crit Care Med 1999; 27 (12): 2662-65.
9. Cooney RN, Yumet G. Cytokine signaling in sepsis: Redundancy, crosstalk, and regulatory mechanisms. Crit Care Med 2002; 30 (1): 262-63.
10. Frossard JL, Hadengue A, Pastor CM. New Serum Markers for the Detection of Severe Acute Pancreatitis in Humans. Am J Respir Crit Care Med 2001; 164: 162-70.
11. Frossard JL, Pastor CM. Experimental acute pancreatitis: new insights into pathophysiology. Frontiers in Bioscience 2002; 7: 275-287.
12. Dugernier T, Reynaert MS, Laterre PF. Immunomodulatory Treatment of Severe Acute Pancreatitis. U: Yearbook of Intensive Care and Emergency Medicine 2002; ed. J. L. Vincent, str. 777-91.
13. Šurbatović M. Aktivnost tumor nekrozis faktora u krvi bolesnika sa sepsom različite težine. Magistarski rad. Vojnomedicinska akademija, Beograd 1998.
14. Karakozis S, Hinds MD, Cook JW. The Effects of Interleukin-10 in Hemorrhagic Shock. J Surg Research 2000; 90: 109-12.
15. Brivet FG, Emillie D, Galanaud P. Pro- and anti-inflammatory cytokines during acute severe pancreatitis: An early and sustained response, although unpredictable of death. Crit Care Med 1999; 27 (4): 749-55.